Opioid utilization patterns in United States individuals with sickle cell disease

被引：32

作者：

Ballas, Samir K. ^{[1
]}

Kanter, Julie ^{[2
]}

Agodoa, Irene ^{[3
]}

Howard, Robin ^{[3
]}

Wade, Sally ^{[4
]}

Noxon, Virginia ^{[5
]}

Dampier, Carlton ^{[6
]}

机构：

[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[2] Med Univ South Carolina, Charleston, SC 29425 USA

[3] Global Blood Therapeut, San Francisco, CA USA

[4] Wade Outcomes Res & Consulting, Salt Lake City, UT USA

[5] IBM Watson Hlth, Cambridge, MA USA

[6] Emory Univ, Sch Med, Atlanta, GA 30322 USA

来源：

关键词：

D O I：

10.1002/ajh.25233

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E345 / E347

页数：3

共 7 条

[1] Center for Disease Control and Prevention, 2016, SICKL CELL DIS DAT S
[2] Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]
[3] Characterization of opioid use in sickle cell disease
Han, Jin
Zhou, Jifang
Saraf, Santosh L.
Gordeuk, Victor R.
Calip, Gregory S.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (05) : 479 - 486
[4] Management of sickle cell disease from childhood through adulthood
Kanter, Julie
Kruse-Jarres, Rebecca
[J]. BLOOD REVIEWS, 2013, 27 (06) : 279 - 287
[5] Insurance Status as a Sociodemographic Risk Factor for Functional Outcomes and Health-related Quality of Life Among Youth With Sickle Cell Disease
Robinson, M. Renee
Daniel, Lauren C.
O'Hara, Emily A.
Szabo, Margo M.
Barakat, Lamia P.
[J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (01) : 51 - 56
[6] The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association
Ruta, Nadia S.
Ballas, Samir K.
[J]. PAIN MEDICINE, 2016, 17 (10) : 1793 - 1798
[7] United States Census Bureau, 2018, POP EST STAT POP TOT